Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling
Cell-based gene therapy has become a subject of interest for the treatment of pulmonary arterial hypertension (PAH), a devastating disease characterized by pulmonary artery smooth muscle cell (PASMC) hyperplasia. Mesenchymal stem cells (MSCs) have been recently acknowledged as a potential cell vecto...
Saved in:
Published in | Stem cell research & therapy Vol. 8; no. 1; p. 34 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central
10.02.2017
|
Subjects | |
Online Access | Get full text |
ISSN | 1757-6512 1757-6512 |
DOI | 10.1186/s13287-017-0480-y |
Cover
Loading…